Search results
'I suffered a stroke after my AstraZeneca Covid vaccine'
Daily Express· 7 days agoAstraZeneca has since said that thrombocytopenia syndrome can be a “rare” side effect of the vaccine...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 5 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...
Moderna Has Big AI News. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool via AOL· 2 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 2 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
CDC ending program for free COVID vaccines early for some
The Hill· 7 days agoThe federal government’s Bridge Access Program unveiled last year in anticipation of the COVID-19...
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Medical Xpress· 7 days agoThe virus's exceptional ability to change and evade immune defenses has led the World Health...
Got COVID? You Might Have One of These Newer Strains
US News & World Report· 2 hours agoKP.2, which is the most prevalent variant circulating in the U.S., was responsible for more than 28% of new infections in the last two weeks, according to CDC estimates released Friday. KP.3 ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 5 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
Here's Yet Another Reason to Stay on Top of Your COVID Vaccine Boosters
ScienceAlert via Yahoo News· 4 days agoThe new study suggests we now have even more reason to keep up those regular boosters. "At the start of the COVID-19 pandemic, the world population was immunologically naïve, which is part of ...
